The Need

Injuries involving hemorrhaging from the aorta, particularly in military and trauma settings, pose a significant threat to patients' lives. Current treatment options require clamping which completely restricts blood flow resulting in risks of complications such as coagulopathy and organ failure. There is a pressing need for a device that can control bleeding from a ruptured aorta, allow bloodflow to be maintained, and minimize blood loss.

The Technology

A retrievable stent-graft technology, temporarily implantable, designed to control bleeding from injured blood vessels, specifically the aorta. This device can be implanted percutaneously into the patient's descending aorta, creating a seal at the site of the rupture while allowing for the continuous flow of blood from upstream to downstream of the injury. The technology can also be used for targeted drug delivery to certain regions of the spinal cord.

Advantages

Immediate Bleeding Control: swiftly controls bleeding, reducing the risk of rapid blood loss and its associated complications.

Minimal reduction of Blood flow: blood flow is diverted from the injury site while maintaining flow to local organs and systemically.

Enhanced Patient Survival: By preserving blood flow, this device improves the chances of patient survival until definitive treatment is available.

Patents

Endovascular Appartus for Perfusing Organs in a Body, U.S. Patent 10,278,384

Perfusion Device for Treating an Injured Blood Vessel, U.S. Patent 10,413,301

DEVICES, SYSTEMS, KITS, AND METHODS FOR DRUG DELIVERY TO THE SPINAL CORD, PCT/US2023/019685

A MULTI-LUMEN IMPLANTABLE DEVICE, PCT/US2021/014661

HYBRID RETRIEVABLE STENT GRAFT AND SHUNT FOR PERFUSION PRESERVING HEMORHAGE CONTROL, U.S. App#: 63,506,192